Holen Sie sich die Stockscreener-App
9.74
2.60%
-0.26
Schlusskurs vom Vortag:
$10.00
Offen:
$10.04
24-Stunden-Volumen:
141.14K
Relative Volume:
0.51
Marktkapitalisierung:
$214.32M
Einnahmen:
$52.55M
Nettoeinkommen (Verlust:
$-23.69M
KGV:
-10.36
EPS:
-0.94
Netto-Cashflow:
$-15.29M
1W Leistung:
+0.72%
1M Leistung:
+1.88%
6M Leistung:
+192.49%
1J Leistung:
+223.59%
1-Tages-Spanne:
$9.70
$10.09
1-Wochen-Bereich:
$9.55
$10.28
52-Wochen-Spanne:
$2.38
$10.34
Exagen Inc Stock (XGN) Company Profile
Firmenname
Exagen Inc
Sektor
Branche
Telefon
(760) 560-1501
Adresse
1261 LIBERTY WAY, VISTA, CA
Vergleichen Sie XGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
9.74 | 211.90M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
479.46 | 179.95B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
190.05 | 137.90B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
641.14 | 51.04B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
123.24 | 35.19B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
187.22 | 31.26B | 15.70B | 1.24B | 2.01B | 6.91 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-30 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | Eingeleitet | Craig Hallum | Buy |
| 2022-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-04-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-06-02 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cowen | Outperform |
| 2019-10-14 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Exagen Inc Aktie (XGN) Neueste Nachrichten
Exagen (NASDAQ:XGN) Upgraded at B. Riley - Defense World
Tools to monitor Exagen Inc. recovery probability2025 Stock Rankings & Safe Entry Trade Reports - Newser
Chart based exit strategy for Exagen Inc.Entry Point & Short-Term Trading Opportunity Alerts - Newser
Using data models to predict Exagen Inc. stock movementEarnings Beat & AI Enhanced Execution Alerts - Newser
What makes Exagen Inc. stock price move sharplyMarket Volume Report & Weekly High Momentum Picks - Newser
Using economic indicators to assess Exagen Inc. potentialMarket Trend Review & Precise Buy Zone Tips - Newser
Will earnings trigger a reversal in Exagen Inc.2025 Volume Leaders & Intraday High Probability Setup Alerts - Newser
Price momentum metrics for Exagen Inc. explainedJuly 2025 Summary & Low Drawdown Trading Strategies - Newser
Can technical indicators confirm Exagen Inc.’s reversalMarket Trend Summary & Accurate Trade Setup Notifications - Newser
Live market analysis of Exagen Inc.Weekly Investment Recap & Daily Stock Momentum Reports - Newser
How to forecast Exagen Inc. trends using time seriesJuly 2025 Sector Moves & Verified Swing Trading Watchlists - Newser
Intraday pattern recognizer results for Exagen Inc.July 2025 Chart Watch & Momentum Based Trading Ideas - Newser
Using AI based signals to follow Exagen Inc.July 2025 Outlook & Low Risk High Win Rate Picks - Newser
Combining machine learning predictions for Exagen Inc.Portfolio Gains Summary & Advanced Technical Analysis Signals - Newser
Exagen Inc. (NASDAQ:XGN) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Exagen (NASDAQ:XGN) Now Covered by Analysts at B. Riley - Defense World
Tick level data insight on Exagen Inc. volatilityJuly 2025 Volume & Consistent Growth Equity Picks - Newser
Smart tools for monitoring Exagen Inc.’s price actionMarket Growth Report & Community Consensus Picks - Newser
B. Riley Initiates Exagen at Buy With $15 Price Target - MarketScreener
Exagen initiated with a Buy at B. Riley - TipRanks
Exagen Inc. (NASDAQ:XGN) Receives Average Recommendation of “Buy” from Analysts - Defense World
Published on: 2025-09-11 07:31:01 - Newser
Understanding Exagen Inc.’s price movementWeekly Trade Review & Real-Time Stock Movement Alerts - Newser
Exagen Inc. stock trend forecastGap Up & Weekly Return Optimization Plans - Newser
What recovery options are there for Exagen Inc.Treasury Yields & Fast Gaining Stock Reports - Newser
Can you recover from losses in Exagen Inc.July 2025 Market Mood & Accurate Intraday Trade Tips - Newser
Analyzing net buyer seller activity in Exagen Inc.Portfolio Growth Summary & Weekly Top Gainers Trade List - Newser
Is Exagen Inc. reversing from oversold territoryGap Down & Daily Risk Controlled Trade Plans - Newser
Exagen Inc.’s volatility index tracking explainedJuly 2025 Price Swings & Accurate Intraday Trading Signals - Newser
Top chart patterns to watch in Exagen Inc.Quarterly Profit Summary & Real-Time Buy Zone Alerts - Newser
How to use Fibonacci retracement on Exagen Inc.July 2025 PreEarnings & Precise Swing Trade Entry Alerts - Newser
Applying chart zones and confluence areas to Exagen Inc.Chart Signals & Safe Entry Point Alerts - Newser
Finanzdaten der Exagen Inc-Aktie (XGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):